{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:30:51Z","timestamp":1790397051344,"version":"4.1.0"},"reference-count":166,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00211","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T07:37:32Z","timestamp":1533022652000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Mineral and Bone Disorders After Kidney Transplantation"],"prefix":"10.3389","volume":"5","author":[{"given":"Chandan","family":"Vangala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald T.","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"B1","first-page":"190","article-title":"The fate of bone after renal transplantation","volume":"17","author":"Brandenburg","year":"2004","journal-title":"J Nephrol"},{"key":"B2","first-page":"1566","article-title":"Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation","volume-title":"Transplantation","author":"Brandenburg","year":"2004"},{"key":"B3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/ajkd.2000.8289","article-title":"Bone disease in patients with long-term renal transplantation and normal renal function","volume":"36","author":"Carlini","year":"2000","journal-title":"Am J Kidney Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/ajt.12652","article-title":"Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States","volume":"14","author":"Sukumaran","year":"2014","journal-title":"Am J Transplant."},{"key":"B7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/TP.0000000000000808","article-title":"Fracture incidence in adult kidney transplant recipients","volume":"100","author":"Naylor","year":"2016","journal-title":"Transplantation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/ajt.14557","article-title":"OPTN\/SRTR 2016 annual data report: kidney","volume":"18","author":"Hart","year":"2018","journal-title":"Am J Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"G533","DOI":"10.1152\/ajpgi.1982.242.5.G533","article-title":"Regulation of Na+-Pi cotransport by 1,25-dihydroxyvitamin D3 in rabbit duodenal brush-border membrane","volume":"242","author":"Hildmann","year":"1982","journal-title":"Am J Physiol"},{"key":"B10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1681\/ASN.V9101845","article-title":"High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro","volume":"9","author":"Almaden","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrneph.2015.153","article-title":"Phosphate and FGF-23 homeostasis after kidney transplantation","volume":"11","author":"Baia","year":"2015","journal-title":"Nat Rev Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/sj.ki.5000148","article-title":"The renal Na+\/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone","volume":"69","author":"Bacic","year":"2006","journal-title":"Kidney Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1523-1755.2005.00506.x","article-title":"Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules","volume":"68","author":"Baum","year":"2005","journal-title":"Kidney Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"c94","DOI":"10.1159\/000086347","article-title":"Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism","volume":"101","author":"Nishi","year":"2005","journal-title":"Nephr Clin Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.clinbiochem.2011.01.009","article-title":"Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease","volume":"44","author":"Filler","year":"2011","journal-title":"Clin Biochem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1172\/JCI32409","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1681\/ASN.2009040427","article-title":"FGF23 fails to inhibit uremic parathyroid glands","volume":"21","author":"Canalejo","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.7326\/0003-4819-78-3-357","article-title":"Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects","volume":"78","author":"Massry","year":"1973","journal-title":"Ann Intern Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"379082","DOI":"10.1155\/2009\/379082","article-title":"FGF-23 Levels before and after Renal Transplantation","volume":"2009","author":"Economidou","year":"2009","journal-title":"J Transpl"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2215\/CJN.01310308","article-title":"Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation","volume":"3","author":"Evenepoel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.transproceed.2015.06.025","article-title":"Impact of renal transplantation and nephrectomy on urinary soluble klotho protein","volume":"47","author":"Kimura","year":"2015","journal-title":"Transpl Proceed"},{"key":"B27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.transproceed.2012.07.150","article-title":"The impact of nephrectomy and renal transplantation on serum levels of soluble Klotho protein","volume":"45","author":"Akimoto","year":"2013","journal-title":"Transpl Proceed"},{"key":"B28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2215\/CJN.04730510","article-title":"Effects of dietary phosphate and calcium intake on fibroblast growth factor-23","volume":"6","author":"Vervloet","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy005","article-title":"Effects of lower versus higher phosphate diets on fibroblast growth factor-23 levels in patients with chronic kidney disease: a systematic review and meta-analysis","author":"Tsai","year":"2018","journal-title":"Nephrol Dialysis Transpl"},{"key":"B30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","article-title":"Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans","volume":"25","author":"Ito","year":"2007","journal-title":"J Bone Mineral Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","article-title":"Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men","volume":"70","author":"Nishida","year":"2006","journal-title":"Kidney Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1744-9987.2005.00293.x","article-title":"Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients","volume":"9","author":"Koiwa","year":"2005","journal-title":"Ther Apheresis Dialysis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/ctr.12291","article-title":"Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice","volume":"28","author":"Muirhead","year":"2014","journal-title":"Clin Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1001\/archsurg.1985.01390290056009","article-title":"Management of hypercalcemic hyperparathyroidism after renal transplantation","volume":"120","author":"Garvin","year":"1985","journal-title":"Arch Surg."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","article-title":"Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study","volume":"19","author":"Evenepoel","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7126290","DOI":"10.1155\/2016\/7126290","article-title":"Prevalence of hypercalcaemia in a renal transplant population: a single centre study","volume":"2016","author":"Amin","year":"2016","journal-title":"Int J Nephrol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/TP.0000000000000823","article-title":"A prospective cohort study of mineral metabolism after kidney transplantation","volume":"100","author":"Wolf","year":"2016","journal-title":"Transplantation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2215\/CJN.06200614","article-title":"Mineral metabolism in European children living with a renal transplant: a European society for paediatric nephrology\/european renal association-European dialysis and transplant association registry study","volume":"10","author":"Bonthuis","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12020-014-0400-1","article-title":"Changes in bone mineral metabolism parameters, including FGF23, after discontinuing cinacalcet at kidney transplantation","volume":"49","author":"Barros","year":"2015","journal-title":"Endocrine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/omcr\/omu033","article-title":"Sarcoidosis presenting with hypercalcaemia following withdrawal of long-term immunosuppression in renal transplantation","volume":"2014","author":"Wong","year":"2014","journal-title":"Oxf Med Case Reports"},{"key":"B41","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0140-6736(85)90437-4","article-title":"Acquired cystic disease of kidney: metastatic renal adenocarcinoma and hypercalcaemia","volume":"2","author":"Thomson","year":"1985","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/00007890-198912000-00022","article-title":"Lymphoma and hypercalcemia in a pediatric orthotopic liver transplant patient","volume":"48","author":"Nakazato","year":"1989","journal-title":"Transplantation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1111\/ajt.12911","article-title":"A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism","volume":"14","author":"Evenepoel","year":"2014","journal-title":"Am J Transplant"},{"key":"B44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.surg.2015.08.039","article-title":"Parathyroidectomy is underused in patients with tertiary hyperparathyroidism after renal transplantation","volume":"159","author":"Lou","year":"2016","journal-title":"Surgery"},{"key":"B45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/000313481408000717","article-title":"Near total parathyroidectomy is effective therapy for tertiary hyperparathyroidism","volume":"80","author":"Dewberry","year":"2014","journal-title":"Am Surg."},{"key":"B46","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2215\/CJN.03920808","article-title":"Calcium metabolism in the early posttransplantation period","volume":"4","author":"Evenepoel","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0272-6386(12)70118-X","article-title":"Musculoskeletal complications after renal transplantation: pathogenesis and treatment","volume":"19","author":"Julian","year":"1992","journal-title":"Am J Kidney Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bone.2012.06.027","article-title":"Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation","volume":"51","author":"Tomida","year":"2012","journal-title":"Bone"},{"key":"B49","doi-asserted-by":"publisher","first-page":"C227","DOI":"10.1152\/ajpcell.1982.243.5.C227","article-title":"Mechanism of glucocorticoid effect on renal transport of phosphate","volume":"243","author":"Turner","year":"1982","journal-title":"Am J Physiol"},{"key":"B50","first-page":"11","article-title":"Effect of glucocorticoids on the passive transport of phosphate in different segments of the intestine in the rat","volume":"2","author":"Yeh","year":"1987","journal-title":"Bone Mineral"},{"key":"B51","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/BF02405375","article-title":"Interrelation of cortisone and 1,25 dihydroxycholecalciferol on intestinal calcium and phosphate absorption","volume":"36","author":"Yeh","year":"1984","journal-title":"Calcified Tissue Int"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/j.1600-6143.2011.03590.x","article-title":"Rapamycin-induced hypophosphatemia and insulin resistance are associated with mTORC2 activation and Klotho expression","volume":"11","author":"Tataranni","year":"2011","journal-title":"Am J Transplant"},{"key":"B53","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/ndt\/16.2.378","article-title":"Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression","volume":"16","author":"Schwarz","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"B54","doi-asserted-by":"publisher","first-page":"F925","DOI":"10.1152\/ajprenal.2000.278.6.F925","article-title":"Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure","volume":"278","author":"Kwon","year":"2000","journal-title":"Am J Physiol Renal Physiol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-222851","article-title":"Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration","author":"Klein","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B56","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MNH.0000000000000329","article-title":"Iron-induced hypophosphatemia: an emerging complication","volume":"26","author":"Zoller","year":"2017","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"B57","doi-asserted-by":"publisher","first-page":"468675","DOI":"10.1155\/2015\/468675","article-title":"Intravenous iron administration and hypophosphatemia in clinical practice","volume":"2015","author":"Hardy","year":"2015","journal-title":"Int J Rheumatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2215\/CJN.10270916","article-title":"Post-transplant hypophosphatemia and the risk of death-censored graft failure and mortality after kidney transplantation","volume":"12","author":"van","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2215\/CJN.07090716","article-title":"Association of serum phosphorus concentration with mortality and graft failure among kidney transplant recipients","volume":"12","author":"Jeon","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/ajcn\/87.2.431","article-title":"Vitamin D status in kidney transplant patients: need for intensified routine supplementation","volume":"87","author":"Ewers","year":"2008","journal-title":"Am J Clin Nutr."},{"key":"B63","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1684\/ejd.2015.2524","article-title":"Vitamin D in Norwegian renal transplant recipients: a longitudinal study with repeated measurements in winter and summer","volume":"25","author":"Rizvi","year":"2015","journal-title":"Eur J Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1111\/j.1600-6143.2007.01978.x","article-title":"Vitamin D status in renal transplant recipients","volume":"7","author":"Stavroulopoulos","year":"2007","journal-title":"Am J Transplant"},{"key":"B65","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1210\/jc.2005-0547","article-title":"25-hydroxyvitamin D deficiency in renal transplant recipients","volume":"91","author":"Querings","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.transproceed.2017.07.009","article-title":"Seasonal variation of vitamin D status in long-term kidney transplant recipients","volume":"49","author":"Wilimborek","year":"2017","journal-title":"Transplant Proc."},{"key":"B67","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/jc.2014-3012","article-title":"Associations of 25(OH) and 1,25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients","volume":"100","author":"Keyzer","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1681\/ASN.2012060614","article-title":"Vitamin D status and outcomes after renal transplantation","volume":"24","author":"Bienaime","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2054358117699822","DOI":"10.1177\/2054358117699822","article-title":"The risk of acute rejection following kidney transplant by 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D status: a prospective cohort study","volume":"4","author":"Zimmerman","year":"2017","journal-title":"Can J Kidney Health Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.trim.2016.11.003","article-title":"Clinical effects of pre-transplant serum 25-hydroxyvitamin D level on post-transplant immunologic and non-immunologic outcomes in kidney transplant recipients","volume":"40","author":"Ban","year":"2017","journal-title":"Transpl Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/TP.0000000000000055","article-title":"Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients","volume":"98","author":"Lee","year":"2014","journal-title":"Transplantation"},{"key":"B72","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1046\/j.1523-1755.2002.00101.x","article-title":"1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants","volume":"61","author":"Redaelli","year":"2002","journal-title":"Kidney Int."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/ctr.12829","article-title":"1,25 Dihydroxyvitamin D circulating levels, calcitriol administration, and incidence of acute rejection, CMV infection, and polyoma virus infection in renal transplant recipients","volume":"30","author":"Moscarelli","year":"2016","journal-title":"Clin Transplant"},{"key":"B74","doi-asserted-by":"publisher","first-page":"95","DOI":"10.6002\/ect.2013.0201","article-title":"25-hydroxyvitamin D deficiency and opportunistic viral infections after kidney transplant","volume":"12","author":"Rech","year":"2014","journal-title":"Exp Clin Transplant."},{"key":"B75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1745-6215-10-36","article-title":"VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome","volume":"10","author":"Thiem","year":"2009","journal-title":"Trials"},{"key":"B76","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s12020-015-0632-8","article-title":"The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes","volume":"50","author":"Sarno","year":"2015","journal-title":"Endocrine"},{"key":"B77","doi-asserted-by":"publisher","first-page":"iv47","DOI":"10.1093\/ndt\/gfs508","article-title":"Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or malignancies in renal transplantation?","volume":"27","author":"Marcen","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1016\/j.transproceed.2016.09.010","article-title":"Relationship between vitamin D blood levels and cancer development in renal transplant patients: a case-control study","volume":"48","author":"Ugalde-Altamirano","year":"2016","journal-title":"Transplant Proc."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1097\/TP.0b013e318172cb2c","article-title":"Pretransplant serum vitamin D levels and risk of cancer after renal transplantation","volume":"85","author":"Ducloux","year":"2008","journal-title":"Transplantation"},{"key":"B80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/tri.12697","article-title":"Vitamin D deficiency is an independent risk factor for PTDM after kidney transplantation","volume":"29","author":"Le","year":"2016","journal-title":"Transpl Int."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/TP.0b013e3182855565","article-title":"Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients","volume":"95","author":"Gonzalez","year":"2013","journal-title":"Transplantation"},{"key":"B82","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/1745-6215-15-430","article-title":"VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial","volume":"15","author":"Courbebaisse","year":"2014","journal-title":"Trials"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/j.1523-1755.2002.kid585.x","article-title":"Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism","volume":"62","author":"Tokumoto","year":"2002","journal-title":"Kidney Int."},{"key":"B84","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1744-9987.2008.00615.x","article-title":"Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism","volume":"12","author":"Matsuoka","year":"2008","journal-title":"Ther Apher Dial."},{"key":"B85","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1399-0012.2007.00690.x","article-title":"Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure","volume":"21","author":"Egbuna","year":"2007","journal-title":"Clin Transplant"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/01.tp.0000287430.19960.0e","article-title":"Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft","volume":"84","author":"Yakupoglu","year":"2007","journal-title":"Transplantation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s004670050772","article-title":"Evolution of secondary hyperparathyroidism after renal transplantation","volume":"14","author":"Koch","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1016\/j.transproceed.2007.10.001","article-title":"Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients","volume":"39","author":"Lehmann","year":"2007","journal-title":"Transplant Proceed"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1172\/JCI28084","article-title":"Glucocorticoids suppress bone formation via the osteoclast","volume":"116","author":"Kim","year":"2006","journal-title":"J Clin Invest"},{"key":"B91","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00223-006-0019-1","article-title":"The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis","volume":"79","author":"van","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporosis Int."},{"key":"B93","doi-asserted-by":"publisher","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","article-title":"Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study","volume":"119","author":"Laan","year":"1993","journal-title":"Ann Int Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.transproceed.2017.07.005","article-title":"Effects of cyclosporine, tacrolimus, and rapamycin on osteoblasts","volume":"49","author":"Martin-Fernandez","year":"2017","journal-title":"Transplant Proceed"},{"key":"B95","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1681\/ASN.2017080849","article-title":"Magnesium and risk of hip fracture among patients undergoing hemodialysis","volume":"29","author":"Sakaguchi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/ndt\/gfq397","article-title":"Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease","volume":"26","author":"Carrero","year":"2011","journal-title":"Nephrol Dialysis Transplant"},{"key":"B97","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12020-018-1543-2","article-title":"Rapid recovery of hypogonadism in male patients with end stage renal disease after renal transplantation","volume":"60","author":"Reinhardt","year":"2018","journal-title":"Endocrine"},{"key":"B98","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1053\/j.ajkd.2016.09.019","article-title":"Proton pump inhibitor use and risk of hip fracture in kidney transplant recipients","volume":"69","author":"Lenihan","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00007890-198602000-00010","article-title":"The decreased incidence of aseptic necrosis in renal transplant recipients\u2013a case control study","volume":"41","author":"Parfrey","year":"1986","journal-title":"Transplantation"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/ndt\/gfh982","article-title":"Bilateral femoral capital avascular necrosis in a renal transplant recipient on tacrolimus-based immunosuppression","volume":"20","author":"Nayagam","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"B101","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/01.blo.0000093908.26658.df","article-title":"Tacrolimus may be associated with lower osteonecrosis rates after renal transplantation","volume":"2003","author":"Sakai","year":"","journal-title":"Clin Orthop Relat Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jsbmb.2009.02.007","article-title":"Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action","volume":"114","author":"Kerachian","year":"2009","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/scrt98","article-title":"Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head","volume":"3","author":"Rackwitz","year":"2012","journal-title":"Stem Cell Res Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ki.2009.188","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","author":"Kidney","year":"2009","journal-title":"Kidney Int Suppl."},{"key":"B105","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","article-title":"KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"70","author":"Isakova","year":"2017","journal-title":"Am J Kidney Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy","volume":"48","author":"Van","year":"2003","journal-title":"Arthritis Rheum."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1111\/j.1600-6143.2008.02423.x","article-title":"Can DXA predict fractures in renal transplant patients?","volume":"8","author":"Akaberi","year":"2008","journal-title":"Am J Transplant"},{"key":"B108","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00198-014-2813-3","article-title":"Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis","volume":"26","author":"Bucur","year":"2015","journal-title":"Osteoporos Int."},{"key":"B109","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2013a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dialysis Transplant."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD","volume":"7","author":"Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/jbmr.2406","article-title":"Bone mineral density predicts fractures in chronic kidney disease","volume":"30","author":"West","year":"2015","journal-title":"J Bone Min Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1097\/01.TP.0000438200.84154.1a","article-title":"FRAX predicts fracture risk in kidney transplant recipients","volume":"97","author":"Naylor","year":"2014","journal-title":"Transplantation"},{"key":"B113","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"Naylor","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/jbmr.2358","article-title":"Longitudinal HR-pQCT and image registration detects endocortical bone loss in kidney transplantation patients","volume":"30","author":"Nishiyama","year":"2015","journal-title":"J Bone Mineral Res"},{"key":"B115","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","article-title":"Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice","volume":"78","author":"Harvey","year":"2015","journal-title":"Bone"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00198-015-3424-3","article-title":"Trabecular bone score in kidney transplant recipients","volume":"27","author":"Naylor","year":"2016","journal-title":"Osteoporosis Int"},{"key":"B117","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2215\/CJN.09850916","article-title":"Spine trabecular bone score as an indicator of bone microarchitecture at the peripheral skeleton in kidney transplant recipients","volume":"12","author":"Luckman","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1046\/j.1523-1755.1999.00445.x","article-title":"Bone loss in long-term renal transplantation: histopathology and densitometry analysis","volume":"55","author":"Cueto-Manzano","year":"1999","journal-title":"Kidney Int."},{"key":"B119","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/TP.0b013e3182985468","article-title":"Persistence of bone and mineral disorders 2 years after successful kidney transplantation","volume":"96","author":"Neves","year":"2013","journal-title":"Transplantation"},{"key":"B120","first-page":"941","article-title":"Serial histomorphometric and histochemical bone biopsy studies in dialysis and transplantation","volume":"81","author":"Bonomini","year":"1975","journal-title":"J Urol Nephrol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0272-6386(04)00955-2","article-title":"Histologic evolution of bone disease 6 months after successful kidney transplantation","volume":"44","author":"Cruz","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B122","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"N Engl J Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/ndt\/16.6.1245","article-title":"Association of sex hormone status with the bone loss of renal transplant patients","volume":"16","author":"Cueto-Manzano","year":"2001","journal-title":"Nephrol Dial Transplant."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1097\/01.TP.0000068869.21770.F6","article-title":"Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients","volume":"75","author":"Cueto-Manzano","year":"2003","journal-title":"Transplantation"},{"key":"B125","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0272-6386(99)70045-4","article-title":"Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid\/base homeostasis","volume":"34","author":"Ambuhl","year":"1999","journal-title":"Am J Kidney Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/ndt\/gfu011","article-title":"Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study","volume":"29","author":"Cozzolino","year":"2014","journal-title":"Nephrol Dialysis Transplant"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/ndt\/gft434","article-title":"Antifibrotic, nephroprotective effects of paricalcitol versus calcitriol on top of ACE-inhibitor therapy in the COL4A3 knockout mouse model for progressive renal fibrosis","volume":"29","author":"Rubel","year":"2014","journal-title":"Nephrol Dialysis Transplant"},{"key":"B128","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5414\/CNP88FX26","article-title":"Effects of paricalcitol on biomarkers of inflammation and fibrosis in kidney transplant recipients: results of a randomized controlled trial","volume":"88","author":"Oblak","year":"2017","journal-title":"Clin Nephrol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/tri.12973","article-title":"Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study","volume":"30","author":"Pihlstrom","year":"2017","journal-title":"Transplant Int"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/ndt\/gfh925","article-title":"Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism","volume":"20","author":"Serra","year":"2005","journal-title":"Nephrol Dial Transplant."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/ndt\/gfh924","article-title":"The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism","volume":"20","author":"Kruse","year":"2005","journal-title":"Nephrol Dial Transplant."},{"key":"B132","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1111\/j.1600-6143.2006.01475.x","article-title":"Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet","volume":"6","author":"Leca","year":"2006","journal-title":"Am J Transplant."},{"key":"B133","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/01.tp.0000232452.80018.ad","article-title":"Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism","volume":"82","author":"Szwarc","year":"2006","journal-title":"Transplantation"},{"key":"B134","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/nep.12186","article-title":"Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study","volume":"19","author":"Torregrosa","year":"2014","journal-title":"Nephrology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1016\/j.transproceed.2012.09.049","article-title":"Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up","volume":"44","author":"Paschoalin","year":"2012","journal-title":"Transplant Proc."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/TP.0b013e31826c3968","article-title":"Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis","volume":"94","author":"Cohen","year":"2012","journal-title":"Transplantation"},{"key":"B137","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/ndt\/gfn579","article-title":"Regression of parathyroid gland swelling by treatment with cinacalcet","volume":"24","author":"Terawaki","year":"2009","journal-title":"Nephrol Dial Transplant."},{"key":"B138","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1016\/j.transproceed.2010.06.027","article-title":"Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism","volume":"42","author":"Cho","year":"2010","journal-title":"Transplant Proc."},{"key":"B139","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/TP.0b013e31817c13e1","article-title":"Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism","volume":"86","author":"Bergua","year":"2008","journal-title":"Transplantation"},{"key":"B140","doi-asserted-by":"publisher","first-page":"31","DOI":"10.12659\/AOT.883809","article-title":"Development of nephrolithiasis in a renal transplant patient during treatment with Cinacalcet","volume":"18","author":"Seager","year":"2013","journal-title":"Ann Transplant."},{"key":"B141","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/TP.0b013e31822d87e8","article-title":"Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism","volume":"92","author":"Zitt","year":"2011","journal-title":"Transplantation"},{"key":"B142","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/TP.0b013e318186b7fb","article-title":"Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation","volume":"86","author":"Borchhardt","year":"2008","journal-title":"Transplantation"},{"key":"B143","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1600-6143.2007.02136.x","article-title":"Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation","volume":"8","author":"Serra","year":"2008","journal-title":"Am J Transplant."},{"key":"B144","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5414\/CNP68245","article-title":"Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient","volume":"68","author":"Esposito","year":"2007","journal-title":"Clin Nephrol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrneph.2010.169","article-title":"Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic","volume":"7","author":"Seikrit","year":"2011","journal-title":"Nat Rev Nephrol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.amjmed.2005.09.041","article-title":"Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient","volume":"120","author":"Peng","year":"2007","journal-title":"Am J Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1016\/j.transproceed.2009.06.167","article-title":"Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure","volume":"41","author":"Carrasco","year":"2009","journal-title":"Transplant Proc."},{"key":"B148","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1016\/j.transproceed.2007.07.088","article-title":"Decrease in serum tacrolimus level and rise in serum creatinine under late addition of cinacalcet in a renal transplant recipient with hyperparathyroidism: a case report","volume":"39","author":"Maass","year":"2007","journal-title":"Transplant Proc."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/ndt\/gfm632","article-title":"Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients","volume":"23","author":"Falck","year":"2008","journal-title":"Nephrol Dial Transplant."},{"key":"B150","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2165\/00126839-200809050-00004","article-title":"Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents: a randomized, open-label, crossover, single-centre study in healthy volunteers","volume":"9","author":"Padhi","year":"2008","journal-title":"Drugs R D."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e2679","DOI":"10.1097\/MD.0000000000002679","article-title":"Efficacy and safety of bisphosphonates for low bone mineral density after kidney transplantation: a meta-analysis","volume":"95","author":"Kan","year":"2016","journal-title":"Medicine"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/ctr.12792","article-title":"Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis","volume":"30","author":"Toth-Manikowski","year":"2016","journal-title":"Clin Transplant"},{"key":"B153","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","article-title":"Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate","volume":"14","author":"Coco","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Kidney","year":"2009","journal-title":"Am J Transplant."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice-yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: a randomized controlled trial","volume":"16","author":"Bonani","year":"2016","journal-title":"Am J Transplant"},{"key":"B156","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Eng J Med"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1111\/j.1600-6143.2008.02327.x","article-title":"Effect of teriparatide on early bone loss after kidney transplantation","volume":"8","author":"Cejka","year":"2008","journal-title":"Am J Transplant."},{"key":"B158","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00423-015-1344-5","article-title":"Surgical management of secondary hyperparathyroidism in chronic kidney disease\u2013a consensus report of the European Society of Endocrine Surgeons","volume":"400","author":"Lorenz","year":"2015","journal-title":"Langenbecks Arch Surg."},{"key":"B159","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/TP.0b013e3182530699","article-title":"Tertiary hyperparathyroidism in kidney transplant recipients: characteristics of patients selected for different treatment strategies","volume":"94","author":"Yang","year":"2012","journal-title":"Transplantation"},{"key":"B160","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1681\/ASN.2015060622","article-title":"A Randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism","volume":"27","author":"Cruzado","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1681\/ASN.2015121349","article-title":"Parathyroidectomy or calcimimetic to treat hypercalcemia after kidney transplantation?","volume":"27","author":"Fukagawa","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"e0187025","DOI":"10.1371\/journal.pone.0187025","article-title":"Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) - A systematic review and meta-analysis","volume":"12","author":"Apetrii","year":"2017","journal-title":"PLoS ONE"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2215\/CJN.01910212","article-title":"Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes","volume":"7","author":"Molnar","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.surg.2016.10.003","article-title":"Parathyroidectomy prior to kidney transplant decreases graft failure","volume":"161","author":"Callender","year":"2017","journal-title":"Surgery"},{"key":"B165","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/ctr.12099","article-title":"Impact of post-kidney transplant parathyroidectomy on allograft function","volume":"27","author":"Parikh","year":"2013","journal-title":"Clin Transplant"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.surg.2009.09.026","article-title":"Tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate? A study of long-term outcomes","volume":"146","author":"Pitt","year":"2009","journal-title":"Surgery"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T13:35:16Z","timestamp":1661693716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":166,"alternative-id":["10.3389\/fmed.2018.00211"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00211","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"article-number":"211"}}